Case Report: Confirmed and suspected heparin-induced thrombocytopenia during therapeutic plasma exchange in neuromyelitis optica spectrum disorder: a single-centre case series. [PDF]
Podlecka-Piętowska A +4 more
europepmc +1 more source
Intractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome. [PDF]
Eliaçık S.
europepmc +1 more source
Ravulizumab in neuromyelitis optica spectrum disorder: first clinical experience in Chile. [PDF]
Santibáñez T +4 more
europepmc +1 more source
Primary Central Nervous System Histiocytic Sarcoma During Neuromyelitis Optica Spectrum Disorder. [PDF]
Saito-Sato N, Bae Y, Hashida H.
europepmc +1 more source
Roles of cerebrospinal fluid metabolites in neuromyelitis optica spectrum disorder: Insights from Mendelian randomization. [PDF]
Deng L +6 more
europepmc +1 more source
OCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy. [PDF]
Amaxilati E +4 more
europepmc +1 more source
Risk of Peripheral Artery Disease and Venous Thromboembolism in Patients with Neuromyelitis Optic Spectrum Disorder: A Nationwide Population-Based Cohort Study. [PDF]
Chen XA +7 more
europepmc +1 more source
Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications. [PDF]
Mariotto S +15 more
europepmc +1 more source
Complement C3 inhibitory peptide AMY-101 ameliorates brain injury in a mouse model of NMOSD. [PDF]
Zhu W, He F, Meng F, Wei R, Liang H.
europepmc +1 more source

